Streetbeat News

Products Services

NVO

Oprah Winfrey aired a prime-time special discussing the stigma around weight loss drugs like Ozempic and Wegovy, sharing personal experiences and highlighting the challenges and side effects associated with these medications. The special also touched on the global obesity crisis and the role of medications in its management. Novo Nordisk A/S, the producer of Ozempic and Mounjaro, was mentioned in the context of the increasing conversation around obesity treatments and the company's efforts to combat supply shortages and counterfeit medications.

Portfolio Pulse from Benzinga Neuro

March 19, 2024 | 10:16 am

CRNX

Crinetics Pharmaceuticals announced successful topline results from its PATHFNDR-2 Phase 3 trial of Paltusotine for Acromegaly, achieving the primary and all secondary endpoints. The company expects to submit a New Drug Application (NDA) to the FDA in the second half of 2024.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 10:06 am

XPEV

XPeng reported a significant increase in vehicle deliveries for Q4 2023, totaling 60,158 units, marking a 170.9% rise YoY. The company expanded its physical sales network to 500 stores across 181 cities and grew its self-operated charging station network to 1,108 stations.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 10:04 am

ANSS

CDNS

NVDA

NVDL

SNPS

WISE

The value of AI-themed ETFs in the U.S. has surged to $6.88 billion, driven by Nvidia Corp's strong market performance. Nvidia's focus on AI chips has fueled investor interest, reminiscent of past booms in transformative technologies. The GraniteShares 2x Long NVDA Daily ETF and the Themes Generative Artificial Intelligence ETF have seen significant asset growth. Nvidia's recent product announcement, despite causing a stock dip, boosted shares of companies like Synopsys Inc, Cadence Design Systems Inc, and ANSYS Inc, which will use Nvidia's new processors.

Portfolio Pulse from Benzinga Neuro

March 19, 2024 | 9:57 am

AAPL

GOOG

GOOGL

Ross Gerber criticized Apple Inc.'s reported deal with Google to license Gemini, a set of generative AI models, for iPhone software features. Despite Gerber's pessimism, Apple stock closed 0.64% higher. The deal is seen as a shift in Apple's AI strategy, potentially enhancing its AI capabilities.

Portfolio Pulse from Benzinga Neuro

March 19, 2024 | 9:37 am

JOBY

Joby Aviation, Inc. (NYSE:JOBY) announced it will deliver two electric vertical takeoff and landing (eVTOL) aircraft to MacDill Air Force Base in 2025 under its AFWERX Agility Prime contract with the U.S. Air Force, expanding its partnership.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 9:34 am

BTCUSD

Bitcoin experienced a dramatic drop to $8,900 on BitMEX, diverging from its $67,400 average global price. The flash crash was followed by a swift recovery. Concerns over market exuberance after spot ETF approvals and a spike in futures market volatility were noted. Grayscale and Fidelity Bitcoin ETFs saw significant outflows, with a collective net outflow of $154.3 million for spot Bitcoin ETFs. BitMEX addressed the crash, attributing it to aggressive selling by a few accounts but assured that all systems were normal and funds safe.

Portfolio Pulse from Mehab Qureshi

March 19, 2024 | 9:21 am

BHAT

Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ:BHAT) is shifting its focus to AI financial services, as announced by Dr. Deanna Liu of Golden Strategy Ltd, a subsidiary of BHAT. This move is in response to the growing AI technology and changing market dynamics.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 9:15 am

SHEN

Shenandoah Telecommunications Company (Shentel) (NASDAQ:SHEN) has launched its Glo Fiber service in Salisbury, Maryland, offering 100% fiber optic broadband to initial neighborhoods. The construction, which began in late 2023, aims to cover over 14,000 homes and businesses within 18-24 months.

Portfolio Pulse from Benzinga Newsdesk

March 19, 2024 | 9:09 am

MSFT

OpenAI's CEO Sam Altman addressed speculation about Chief Scientist Ilya Sutskever's absence since a failed attempt to oust Altman in November. On the Lex Fridman Podcast, Altman laughed off rumors about Sutskever being held hostage, confirming Sutskever is still with OpenAI and expressing hope to work together for the rest of his career. Despite past tensions, Altman denies any ill will towards Sutskever and denies that OpenAI, backed by Microsoft Corp. (NASDAQ:MSFT), has achieved artificial general intelligence (AGI).

Portfolio Pulse from Rounak Jain

March 19, 2024 | 9:08 am